Viewing Gene With Clinical Trials Data


Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/

Symbol: AXL
Name: AXL receptor tyrosine kinase
Location: 19q13.2
Locus Group: protein-coding gene
Gene Type: Protein Coding
Locus Type: gene with protein product

Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all

Clinical Studies

NCT Number Status Brief Title View
NCT01561456 Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung View
NCT03572634 Phase 12 Study of TP-0903 an Inhibitor of AXL Kinase in Patients With Previously Treated CLL View
NCT02729298 First-in-human Study of Oral TP-0903 a Novel Inhibitor of AXL Kinase in Patients With Advanced Solid Tumors View
NCT03425201 Niraparib in Combination With Cabozantinib XL184 in Patients With Advanced Urothelial Cancer NICARAGUA View
NCT03536208 Biological Effect of Warfarin on Pancreatic Cancer View
NCT03965494 AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery View
NCT04322630 Mer-TK in Human Cardiac Cells View
NCT05346536 Liquid Biopsy and Pancreas Cancer Detection of AXL CTCs CTC-AXL-PANC View
NCT05551715 Virtual Eye Model System for Personalised Refractive Surgery Treatment View
NCT04316182 Cabozantinib in Patients With Hepatocellular Carcinoma ACTION View
NCT01639508 Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes ROS1 or NTRK Fusions or Increased MET or AXL Activity View
NCT04458259 Study of PF-07265807 in Participants With Metastatic Solid Tumors View
NCT00697632 Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies View
NCT00785278 Adjusting Wheelchair Set-Up to Minimize Shoulder Joint Forces During Propulsion View
NCT02219711 Phase 11b Study of MGCD516 in Patients With Advanced Cancer View
NCT01062620 A Dose Escalating Clinical Trial of the IGF-1 Receptor Inhibitor AXL1717 in Patients With Advanced Cancer View
NCT01139333 Blood and Tumor Tissue Samples From Young Patients With Acute Myeloid Leukemia View
NCT03454243 Oral Immunomodulatory Tyrosine Kinase Inhibitor in Patients With Locally Advanced or Metastatic Solid Tumors View
NCT03393936 Safety and Efficacy of CCT301 CAR-T in Adult Subjects With Recurrent or Refractory Stage IV Renal Cell Carcinoma View
NCT05389462 A Study of Mipasetamab Uzoptirine ADCT-601 in Participants With Solid Tumors View
NCT03522142 A Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies View
NCT02424617 A Study of BGB324Bemcentinib in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer View
NCT02488408 A Phase IbII Multicenter Open-label Study of Bemcentinib BGB324 in Patients With AML or MDS View
NCT05740917 To Evaluate the Phase I Clinical Study of XZB-0004 in Patients With AML and MDS View
NCT03990454 Safety Study of SLC-391 in Subjects With Solid Tumors View
NCT02988817 Enapotamab Vedotin HuMax-AXL-ADC Safety Study in Patients With Solid Tumors View
NCT03176277 A Study of ONO-7475 in Patients With Acute Leukemias View
NCT04600219 The Effect of Tyrosine Kinase Receptor Axl on Dialysis Prognosis in Chronic Hemodialysis Patients View
NCT03396003 A Comparison of Two Devices for Taking Measurements of the Eye to Assist in Lens Selection for Cataract Surgery View
NCT03425279 CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma View
NCT04681131 CAB-AXL-ADC Safety and Efficacy Study in Adults with NSCLC View
NCT03649321 Clinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic Cancer View
NCT06359847 Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer View
NCT03769311 Cetuximab in Head and Neck Cancer Patients View
NCT03824080 Evaluating the Efficacy and Safety of Bemcentinib in Patients With Myelodysplastic Syndromes View
NCT04004442 Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma View
NCT04045626 Study of Demarcation Line Depth in Transepithelial Versus Epithelium-off Accelerated Cross-linking AXL in Keratocouns View
NCT04042623 Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA Nephropathy View
NCT05410717 CLDN6GPC3MesothelinAXL-CAR-NK Cell Therapy for Advanced Solid Tumors View
NCT05860296 Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug Pembrolizumab for Advanced Lung Cancers View
NCT04895215 AB-2004 in Treatment of Irritability Associated With Autism Spectrum Disorder ASD View
NCT05128786 CCT301-38 CAR-T in Patients With Relapsed or Refractory AXL Positive Sarcomas View
NCT02034981 Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK MET or ROS1 View
NCT05772455 A Study of XZB-0004 in Patients With Solid Tumors View
NCT05816785 Pilot Study of Imatinib Cetuximab Combo for H N Cancer View
NCT00949143 Effects of Axle Positions on Wheelchair Skills in Manual Wheelchair Users View
NCT01014468 Bevacizumab Versus Ranibizumab in Age Related Macular Degeneration View
NCT06049667 A Phase 1 Clinical Trail of NTQ2494 Tablets in Patients With Advanced Hematological Malignancies View
NCT06231550 A Study of Axl Inhibitor FC084CSA in Patients With Advanced Malignant Solid Tumors View
NCT06359860 A Study of ST-1898 for Unresectable or Metastatic Melanoma View
NCT06499350 A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors View
NCT04129463 Subscleral Trabeculectomy With Iris Incarceration in Buphthalmous View
NCT03198052 GPC3MesothelinClaudin182GUCY2CB7-H3PSCAPSMAMUC1TGFβHER2Lewis-YAXLEGFR-CAR-T Cells Against Cancers View
NCT03607955 Paclitaxel Carboplatin With AVB-S6-500 in Women With Stage III or IV Epithelial Ovarian Primary Peritoneal or Fallopian Tube Cancer Receiving Neoadjuvant Chemotherapy View